Found 497 matching trials
Immunotherapy for Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), Blast Phase Chronic Myelogenous Leukemia (BP CML), and Myelodysplastic Syndrome (MDS) Relapse After Allogeneic Transplantation PHASE2 The relapse of acute leukemia, MDS and blast phase CML after allogeneic tra...
Show More Location
Emory University Winship Cancer Institute
Learn More & Join Trial
Imatinib Mesylate in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia Who Have Received Chemotherapy PHASE2 RATIONALE: Imatinib mesylate may stop the growth of cancer cells by blockin...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
Idarubicin, Cytarabine, and Gemtuzumab Ozogamicin in Treating Patients With Previously Untreated High-Risk Myelodysplastic Syndrome or Acute Myeloid Leukemia Secondary to Myelodysplastic Syndrome PHASE2 RATIONALE: Drugs used in chemotherapy, such as idarubicin and cytarabine, w...
Show More Learn More & Join Trial
Cognitive and Vascular Functioning Following TBI N/A This observational study will examine the association of chronic traumatic ...
Show More Location
Walter Reed National Military Medical Center
Learn More & Join Trial
Combination Chemotherapy in Treating Children With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome PHASE3 RATIONALE: Drugs used in chemotherapy use different ways to stop cancer cel...
Show More Location
Algemeen Ziekenhuis Middelheim
Learn More & Join Trial
Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia N/A Adult acute lymphoblastic leukemia treatment approaches relie on risk strat...
Show More Location
CRLCC Centre Paul Papin
Learn More & Join Trial
NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders PHASE2 RATIONALE: Giving low doses of chemotherapy before a donor peripheral blood...
Show More Location
Roswell Park Cancer Institute
Learn More & Join Trial
Study of Treatment With Nilotinib in Adult Patients With Imatinib - Resistant or - Intolerant Chronic Myeloid Leukemia in Blast Crisis, Accelerated Phase or Chronic Phase PHASE4 Maintain and monitor long-term hematological and cytogenetic responses prev...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of LBH589B in Adult Patients With Refractory Chronic Myeloid Leukemia in Accelerated or Blast Phase PHASE2 This study will evaluate the efficacy and safety of LBH589B in adult patien...
Show More Location
City of Hope National Medical Center
Learn More & Join Trial
Combination Chemotherapy in Treating Patients With Myelodysplastic Syndrome PHASE2 RATIONALE: Drugs used in chemotherapy use different ways to stop tumor cell...
Show More Location
Cancer Center and Beckman Research Institute, City of Hope
Learn More & Join Trial